| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Salarius Pharmaceuticals, Inc. | Exec VP Finance, CFO | Stock Option (right to buy) | 22.5K | Feb 20, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SLRX | Salarius Pharmaceuticals, Inc. | Feb 20, 2024 | 1 | $0 | 4 | Feb 22, 2024 | Exec VP Finance, CFO |
| SLRX | Salarius Pharmaceuticals, Inc. | Feb 13, 2023 | 1 | $0 | 4 | Feb 15, 2023 | Exec VP Finance, CFO |
| SLRX | Salarius Pharmaceuticals, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Exec VP Finance, CFO |
| SLRX | Salarius Pharmaceuticals, Inc. | Nov 3, 2022 | 1 | $2.58K | 4/A | Dec 12, 2022 | Exec VP Finance, CFO |
| SLRX | Salarius Pharmaceuticals, Inc. | Nov 3, 2022 | 1 | $12.7K | 4/A | Nov 8, 2022 | Exec VP Finance, CFO |
| SLRX | Salarius Pharmaceuticals, Inc. | May 31, 2022 | 1 | $5.04K | 4 | May 31, 2022 | Exec VP Finance, CFO |
| SLRX | Salarius Pharmaceuticals, Inc. | May 3, 2022 | 1 | $1.86K | 4 | May 5, 2022 | Exec VP Finance, CFO |
| SLRX | Salarius Pharmaceuticals, Inc. | Mar 3, 2022 | 1 | $29.8K | 4 | Mar 9, 2022 | Exec VP Finance, CFO |
| SLRX | Salarius Pharmaceuticals, Inc. | Jan 20, 2022 | 1 | $0 | 4 | Jan 21, 2022 | Exec VP Finance, CFO |
| SLRX | Salarius Pharmaceuticals, Inc. | Nov 3, 2021 | 1 | $5.59K | 4 | Nov 5, 2021 | Exec VP Finance, CFO |